Researchers have identified biomarkers that can predict disease progression in multiple sclerosis, which could lead to the ...

Motor neuron diseases are a group of progressive and ultimately fatal neurodegenerative disorders of the motor system, ...

NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel ...

The Phase 1 clinical trial is expected to enroll about 60 participants to test how safe and well tolerated multiple doses of ...

PIP is comprised of two components and these are daily living, so if you need help with day-to-day tasks, and mobility, which ...

Dr. Tilman explains the functions of iPSC-derived microglia and their relevance to conditions like Alzheimer’s.

Recent innovations, successful trials, and increased research and development spending in the healthcare sector further boost ...

ATH-1105 is an orally delivered, positive modulator of the neurotrophic HGF system that is currently in a Phase 1 clinical trial with completion ...

CUTS is a cryptic exon RNA biosensor enabling real-time detection of TDP-43 loss of splicing function. CUTS exhibits a significant linear relationship with TDP-43 loss. CUTS can deliver an ...

The Society for Neuroscience (SfN) will honor seven researchers who have made significant contributions to the advancement of women in neuroscience. The awards will be presented during Neuroscience ...

A study presented at ECTRIMS 2024 has identified critical biomarkers that can predict disability worsening in multiple ...